CGM
MRK icon

Capital Growth Management’s Merck MRK Stock Holding History

Capital Growth Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100,000
Closed -$9.12M – 68
2022
Q2 		$9.12M Buy
+100,000
New +$8.87M 1.08% 33
2020
Q2 		– Sell
-73,360
Closed -$5.39M – 56
2020
Q1 		$5.39M Buy
+73,360
New +$5.77M 0.76% 36
2019
Q4 		– Sell
-125,760
Closed -$10.1M – 62
2019
Q3 		$10.1M Buy
+125,760
New +$10.1M 0.77% 33

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Growth Management's MRK Position: Q3 2022 in Review

Capital Growth Management sold out of Merck (MRK) in Q3 2022, closing a stake of 100,000 shares — an estimated $9.12M sold.

Capital Growth Management first reported a position in MRK in Q3 2019 and held it in 3 quarters. The position peaked at $10.1M in Q3 2019. 2,990 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

  • Capital Growth Management reported no remaining Merck position as of Q3 2022 after selling out during the quarter.
  • Capital Growth Management sold 100,000 Merck shares in Q3 2022, an estimated $9.12M.
  • Capital Growth Management first reported a position in Merck in Q3 2019 and held it in 3 quarters.
  • Capital Growth Management's Merck position peaked at $10.1M in Q3 2019.
  • 2,990 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on Capital Growth Management's 13F filing for Q3 2022, filed 14 Nov 2022.